Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Ms. Anita Z. Graham

Executive Vice President & Chief Human Resources Officer

Mr. Peter J. Wilkinson

Senior Vice President & Chief Accounting Officer

Christin  O'Donnell

Vice President of Investor Relations

Mr. Adam H. Schechter

President, Chief Executive Officer & Chairman

Mr. Mark S. Schroeder

Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer

Dr. Brian J. Caveney J.D., M.D., M.P.H.

EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer

Mr. Lance V. Berberian

Executive Vice President and Chief Information & Technology Officer

Ms. Sandra D. van der Vaart

Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Corporate Secretary

Ms. Amy B. Summy

Executive Vice President & Chief Marketing Officer

Mr. Glenn A. Eisenberg

Chief Financial Officer & Executive Vice President

Nom de l'entreprise	Capitalisation boursière
China Health Group Inc.	0M
Revvity, Inc.	0M
Standard BioTools Inc.	0M
IDEXX Laboratories, Inc.	0M
China Biotech Services Holdings Limited	0M
Sonic Healthcare Limited	0M
Quest Diagnostics Incorporated	0M
Qiagen N.V.	0M
Amoy Diagnostics Co., Ltd.	0M
WuXi AppTec Co., Ltd.	0M
Genetic Technologies Limited	0M

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings Liste des concurrents

Principaux concurrents